Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Finasteride improves prostate cancer detection in PSA test.

A semi-automated system can effectively help choose emulsion ingredients, simplifying the creation of medicinal and cosmetic products.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Ganoderma lucidum may help treat enlarged prostate in rats.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Corn silk extract helps reduce prostate enlargement symptoms.

Hair loss gene linked to prostate issues.